FDA records answer “is it approved?”
An FDA drug record shows whether the agency has approved a product. An FDA compounding page tells you whether pharmacies may make a drug from an ingredient. An enforcement letter lists the agency’s concerns about one named seller at the time of the letter.
Trial papers answer “what happened there?”
A trial result describes what happened to the people who joined, using that product, for that length of time, under those study rules. An average cannot predict one person’s result.
Labels answer “what did the FDA review?”
A label gives uses, cautions, and instructions for an approved product. Cagrilintide has no label, so details from semaglutide or pramlintide cannot fill the gap.
Company reports can be early
Some results appear in a company report before a medical journal paper. When that happens, treat the numbers as an early report and check later for a full paper.
Check the date before acting
Cagrilintide’s FDA status could change after September 2026. Compare the date on a claim with the date on the newest FDA record before you rely on it.
Chapter recap
Before trusting a claim, check who made it, which people and product it covers, when the record was checked, and what remains unknown.